文献速递乳腺癌放疗放疗物理与技术

质子束放疗用于局部晚期乳腺癌综合区域淋巴结照射的急性毒性评估

Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer.
PubMed 文献 · Radiother Oncol · 2017-04-27

本研究回顾性评估2011至2016年91例(93侧)乳腺癌患者接受辅助质子束放疗(PBT)靶向全乳/胸壁及综合区域淋巴结的急性毒性。中位随访15.5个月,中位PBT剂量50.4 GyRBE,61例接受后续推量(中位10 GyRBE)。≥3级皮炎发生率5%,8%因皮炎需治疗中断,无3级食管炎;结论认为PBT在综合区域淋巴结照射中毒性可接受。

要点

  • 质子束放疗靶向全乳/胸壁及腋窝、锁骨上、内乳淋巴结,3级皮炎发生率5%。
  • 8%患者因皮炎需治疗中断,皮炎消退中位时间32天。
  • 3级食管炎发生率为0%,1级和2级分别为31%和33%。

核心结论

  • 质子束放疗在综合区域淋巴结照射背景下显示出可接受的急性毒性。

研究设计与样本

  • 回顾性研究纳入2011至2016年91例乳腺癌患者(93侧癌症),接受辅助质子束放疗靶向全乳/胸壁及综合区域淋巴结。
  • 毒性按CTCAE v4.0每周、治疗后1个月及之后每6个月记录,并回顾病历核实。

主要发现

  • 中位随访15.5个月,中位PBT剂量50.4 GyRBE,61例接受后续推量(中位10 GyRBE)。
  • 1级、2级、3级皮炎发生率分别为23%、72%、5%,8%因皮炎需治疗中断,皮炎消退中位时间32天。
  • 1级、2级、3级食管炎发生率分别为31%、33%、0%。

临床怎么用

  • 对于需要综合区域淋巴结照射的局部晚期乳腺癌患者,质子束放疗的急性皮炎和食管炎发生率可供临床决策参考。

局限性

  • 本研究为回顾性研究,中位随访仅15.5个月,样本量91例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study evaluates acute toxicity outcomes in breast cancer patients treated with adjuvant proton beam therapy (PBT). METHODS: From 2011 to 2016, 91 patients (93 cancers) were treated with adjuvant PBT targeting the intact breast/chest wall and comprehensive regional nodes including the axilla, supraclavicular fossa, and internal mammary lymph nodes. Toxicity was recorded weekly during treatment, one month following treatment, and then every 6months according to the Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Charts were retrospectively reviewed to verify toxicities, patient parameters, disease and treatment characteristics, and disease-related outcomes. RESULTS: Median follow-up was 15.5months. Median PBT dose was 50.4 Gray relative biological effectiveness (GyRBE), with subsequent boost as clinically indicated (N=61, median 10 GyRBE). Chemotherapy, when administered, was given adjuvantly (N=42) or neoadjuvantly (N=46). Grades 1, 2, and 3 dermatitis occurred in 23%, 72%, and 5%, respectively. Eight percent required treatment breaks owing to dermatitis. Median time to resolution of dermatitis was 32days. Grades 1, 2, and 3 esophagitis developed in 31%, 33%, and 0%, respectively. CONCLUSIONS: PBT displays acceptable toxicity in the setting of comprehensive regional nodal irradiation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Verma V, Iftekaruddin Z, Badar N, et al. Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer. Radiother Oncol. 2017. PMID: 28457577. doi:10.1016/j.radonc.2017.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。